期刊文献+

福建省散发性肌萎缩侧索硬化症的危险因素分析 被引量:1

Risk Factor Analysis for Sporadic Amyotrophic Lateral Sclerosis Patients from Fujian Province
下载PDF
导出
摘要 目的探索福建省散发性肌萎缩侧索硬化症(ALS)发病的相关危险因素。方法以年龄和性别作为入组匹配因素收集ALS患者(病例组)和对照组,采用χ2检验及Logistic回归进行单因素及多因素分析ALS的相关危险因素。结果病例组外伤史明显高于对照组(P<0.001)。多因素分析显示,头部外伤OR值为3.601(95%可信区间为1.279~10.141),与ALS发病密切相关。每天饮茶1~3杯可能降低ALS风险(调整后OR值为0.355,95%可信区间为0.140~0.898)。结论在福建省散发性ALS患者中,外伤史是其独立的危险因素,以头部外伤更为相关。每天饮茶1~3杯可能降低ALS风险。 Objective To explore the risk factors for sporadic ALS patients from Fujian province.Methods An age-and gender-matched case-control study was performed to collect the ALS-related risk factors.The chi-square test and logistic regression were employed for univariate and multivariate analysis.Results The rate of traumatic events in ALS cases was significant higher than that in the controls(P<0.01),and the adjusted OR of head traumatic event was 3.601(95%CI:1.279-10.141).Besides,drinking tea with one to three cups daily seemed to be protective for ALS(OR:0.355;95%CI:0.140-0.898).Conclusion In this cohort of sporadic ALS patients,traumatic event may link to the increase risk for ALS,and tea consumption seems to be a protective factor.
作者 胡微 郭祈福 许柳青 张奇杰 王柠 HU Wei;GUO Qifu;XU Liuqing;ZHANG Qijie;WANG Ning(Department of Neurology,Fujian Institute of Neurology,The First Affiliated Hospital of Fujian Medical University,Fuzhou 350005,China)
出处 《福建医科大学学报》 2021年第3期196-200,共5页 Journal of Fujian Medical University
基金 国家自然科学基金面上项目(81701133)。
关键词 肌萎缩侧索硬化症 散发性 流行病学 危险因素 福建省 amyotrophic lateral sclerosis sporadic epidemiology risk factor tea Fujian province
  • 相关文献

参考文献2

二级参考文献9

  • 1Brooks BR. EI Escorial World Federation of Neurology criteria for diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the WorldFederation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci, 1994, 124 Suppl : 96-107.
  • 2Brooks BR, Miller RG, Swash M, et al. EI Eseorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 2000, 1: 293 -299.
  • 3de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for the diagnosis of ALS. Clin Neurophys, 2005, 119 : 497 -503.
  • 4Bensimon L,Lacomblez L, Meininger V, et al. A controlled trialof riluzole in amyotrophic lateral sclerosis. N Engl J Med, 1994, 330 : 585-591.
  • 5Miller RG, Jackson CE, Kasarskis E J, et al. Practice parameter update : the care of the patient with amyotrophic lateral sclerosis : multidisciplinary care, symptom management, and cognitive/ behavioral impairment (an evidence-based review ). Neurology, 2009, 73 : 1227-1233.
  • 6Andersen PM, Borasio GD, Dengler R, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosis and clinical care of patients and relatives. Eur J Neurol, 2005, 12:921-938.
  • 7牛艳芳,熊慧玲,邬剑军,陈嬿,乔凯,吴志英.肌萎缩侧索硬化患者SOD1基因突变检测及突变与临床表型的关系[J].遗传,2011,33(7):720-724. 被引量:9
  • 8吕传真,蒋雨平.肌萎缩侧索硬化的诊断标准(草案)[J].中华神经科杂志,2001,34(3):190-190. 被引量:99
  • 9Satoshi Yamashita,Yukio Ando.Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis[J].Translational Neurodegeneration,2015,4(1):92-104. 被引量:11

共引文献113

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部